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Ischemic colitis due to medications is common, and a number of cases have been described with pseudoephedrine as the culprit
agent.Wepresent here an interesting case of a healthy femalewith no risk factorswhodeveloped pseudoephedrine induced ischemic
colitis. This case serves to remind the healthcare providers about the utmost importance of obtaining a comprehensive history to
aid with the diagnosis.
1. Introduction
Ischemic colitis is caused due to the sudden interruption of
blood supply of the bowel, which results in ischemic injury
particularly to the watershed areas. Risk factors associated
with ischemic colitis include age, female gender, cardiovascu-
lar conditions, autoimmune diseases, hypercoagulable state,
and medications [1].
Various case reports have been published linking is-
chemic colitis to numerous medications [1]. We present an
interesting case of a patient with no medical comorbidities
who presented with ischemic colitis likely associated with
pseudoephedrine.
2. Case Report
A 54-year-old previously healthy Caucasian female with
otherwise unremarkable past medical history presented to
emergency departmentwith one-day history of hematochezia
and abdominal pain.The patient described crampy left lower
quadrant pain with no aggravating or relieving factors. She
had a total of five bowel movements since symptom onset
with the first bowel movement containing stool mixed with
bright red blood followed by predominantly bloody stools.
She took nomedications on a regular basis and denied having
a screening colonoscopy for colorectal cancer at age 50. She
reported symptoms of upper respiratory tract infection (cold,
sneeze, and cough) for which she took three doses of 120 mg
pseudoephedrine purchased from a local grocery store for 1
day prior to symptom onset. Her maternal grandfather had
prostate cancer but there was no significant gastrointestinal
tumor history in the family. She was a nonsmoker and
reported drinking socially (roughly one standard drink) once
a week.
Her admission vitals were within normal limits. Physical
examination was consistent with mild tenderness on the left
side of abdomen and hypoactive bowel sounds. Rectal exami-
nation showed bright red bloodwithout any stool in the rectal
canal. Her laboratory values were significant for mild anemia
with hemoglobin of 11.5 mg/dl, hematocrit of 34.5%, erythro-
cyte sedimentation rate 31 mm/hr, and C-reactive protein
2.15 mg/dl. A computed tomography scan revealed mild to
moderate mural thickening of the descending/sigmoid colon
consistent with colitis without pericolonic abscess, ascites,
or free air (Figure 1). An infectious workup was obtained
including blood cultures, stool cultures, gastrointestinal panel
for Clostridium difficile, and gastrointestinal viruses but was
negative. She was resuscitated with intravenous fluids.
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Figure 1: Transverse section of computed tomography scan demon-
strating mild to moderate mural thickening of the descend-
ing/sigmoid colon (arrows) consistent with colitis without peri-
colonic abscess, ascites, or free air.
Figure 2: Colonoscopy demonstrating segmental moderate inflam-
mation in the sigmoid colon, descending colon, and splenic flexure.
The patient underwent colonoscopy which demonstrated
segmental moderate inflammation in the sigmoid colon,
descending colon and splenic flexure along with internal
and external hemorrhoids. There was evidence of submu-
cosal hemorrhages with mild edema in the aforementioned
segments of the colon (Figure 2). Endoscopic findings were
highly suspicious of ischemic colitis. Several biopsies were
obtained from the inflamed areas which exhibited focal lam-
ina propria eosinophilic change with mild crypt attenuation
and loss of goblet cells consistent withmild ischemic changes.
There was no evidence of chronic inflammation.
She was observed in the hospital for 3 days and her diet
was progressed slowly. Her bloody bowel movements ceased
after 1 day in the hospital and patient was counseled and
educated regarding avoidance of pseudoephedrine and over
the counter medications for symptomatic management.
3. Discussion
This case demonstrates the occurrence of ischemic colitis in
an otherwise healthy female who did not have any major
risk factors that would predispose her to ischemic colitis.
Medications are an increasingly common cause of ischemic
colitis [1], which led us to do an extensive inquiry into over
the counter drugs, herbal medications, complementary, and
alternative management. The fact that the patient improved
with conservative measures and has remained disease free
since recovering from her initial injury favors medication
as the culprit for causing ischemic colitis as opposed to a
thrombotic or autoimmune disease. The patient scored an 8
on the Naranjo scoring system which classifies this event as
a probable drug reaction [2] (Table 1). A thorough workup
for autoimmune conditions was not carried out as the patient
did not have any other symptoms and has also been disease-
free since her discharge. Similarly, anticoagulation workup
was not performed as the patient did not have evidence of
clots or thrombus on the CT scan obtained nor did she have
a previous history of thromboembolism.
Data are available in the literature on variousmedications
causing ischemic colitis with different mechanisms of action
[1]. Drugs such as norepinephrine, ephedrine, phenylephrine,
phentermine, methamphetamine, vasopressin, epinephrine,
cocaine, ergotamine, triptans, and ephedra cause vasocon-
striction in the bowel predisposing the gut to ischemia par-
ticularly at the watershed area. Antihypertensive medications
such as angiotensin converting enzyme inhibitors, diuretics,
calcium channel blockers, and nitrates can cause ischemia
by decreasing preload and reducing the blood supply to the
affected organ. Thromboembolism is implicated with the
use of oral contraceptive use and hormones. Other novel
mechanisms have been proposed for other medications such
as vasculitis with gold salts and increase colonic luminal pres-
sure and subsequently decreased blood supply by alosetron
[3]. Several other medications are implicated with causing
ischemic colitis but the mechanism of action is unclear
[4].
Pseudoephedrine is a commonly used over the counter
medication for cold and allergy symptoms. It is a sympath-
omimetic drug with a direct agonistic effect on 𝛼- and 𝛽2-
adrenergic receptors causing vasoconstriction of blood ves-
sels and relaxation of smooth muscles in the bronchi, respec-
tively. This sympathomimetic action is likely responsible for
causing ischemia in the gut as mentioned with other drugs
related to same category above. After an extensive literature
search, we found ten cases that suggested pseudoephedrine as
the culprit agent for causing ischemic colitis [5–11] (Table 2).
The dose of pseudoephedrine ingested varied across these
cases with a range of 60 mg/day to 900 mg/day. Similarly, the
duration of pseudoephedrine use ranged from as minimal as
5 days to 2 years. All the cases recovered uneventfully except
one that required immediate surgical interventionwith right-
sided ischemic colitis. Our case is unique as our patient took
only 3 doses of 120 mg of the drug for just one day and
developed symptoms. This is the lowest possible exposure
reported in the literature.
In conclusion, medications are an important factor that
predisposes an individual to develop ischemic colitis. Our
case report exemplifies that pseudoephedrine may cause
ischemic colitis. Moreover, we would like to stress to health-
care providers (clinicians, nurse practitioners, assistant physi-
cians, and medical students) the importance of detailed
history and review of medications including prescription
drugs, over the countermedications, herbal supplements, and
alternative treatments to aid in the diagnosis of this condi-
tion.
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Table 1: Naranjo scoring algorithm for determining possibility of drug reaction, scoring: ≥ 9 = definite ADR, 5-8 = probable ADR, 1-4 =
possible ADR, and 0 = doubtful ADR.
Question Yes No NA Points
1. Are there previous conclusive reports on this reaction?Yes (+1) No (0) NA (0) X 1
2.
Did the adverse events appear after the suspected drug
was given?
Yes (+2) No (-1) NA (0)
X 2
3.
Did the adverse reaction improve when the drug was
discontinued or a specific antagonist was given?
Yes (+2) No (-1) NA (0)
X 2
4.
Did the adverse reaction appear when the drug was
readministered?
Yes (+2) No (-1) NA (0)
X 0
5.
Are there alternative causes that could have caused the
reaction?
Yes (-1) No (+2) NA (0)
X 2
6. Did the reaction reappear when a placebo was given?Yes (-1) No (+1) NA (0) X 0
7.
Was the drug detected in any body fluid in toxic
concentrations?
Yes (+1) No (0) NA (0)
X 0
8.
Was the reaction more severe when the dose was
increased, or less severe when the dose was decreased?
Yes (+1) No (0) NA (0)
X 0
9.
Did the patient have a similar reaction to the same or
similar drugs in any previous exposure?
Yes (+1) No (0) NA (0)
X 0
10.
Was the adverse event confirmed by any objective
evidence?
Yes (+1) No (0) NA (0)
X 1
Table 2: Previously reported dosing for pseudoephedrine in patients presenting with ischemic colitis.
S. No Author Year Dose and Frequency Sequela
1. Schneider 1995 Pseudoephedrine 240 mg daily for 5 days Resolved
2. Dowd 1999
Three patients used pseudoephedrine 120 mg twice
daily for 7 days and one patient used 120 mg daily for 6
months
Resolved
3. Lichtensteinet al. 2000
Sudafed (Pseudoephedrine) 120 mg twice daily for 5
days Resolved
4. Klestov et al. 2001
Nucosef daily (14.9 mg codeine + 60 mg
pseudoephedrine) for 2 years and 900 mg daily








5. Traino et al. 2004 Pseudoephedrine 240 mg per day for 7 days + tramadol150 mg per day for chronic back pain Resolved
6. Sherid et al. 2014 Sudafed (Pseudoephedrine) 120 mg twice daily for 5days Resolved
7. Ambesh et al. 2017 Pseudoephedrine hydrochloride, 10 mg four times dailyfor 1 month Resolved
8. Aziz et al. 2018 Pseudoephedrine 120 mg × 3 in one day Resolved
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